
    
      Observational Objectives:

      To describe the safety of evaluated vaccine, given in the two-dose schedule in accordance
      with the Package Insert, in children aged ≥ 6 months to ≤ 36 months,6th to 12th birthday and
      ≥ 60th birthday.

      To describe the immunogenicity of evaluated vaccine, given in the two-dose schedule in
      accordance with the Package Insert, in children aged ≥ 6 months to ≤ 36 months, 6th to 12th
      birthday and ≥ 60rd birthday.
    
  